License to SPONSOR Sample Clauses

License to SPONSOR. The Institution and the Principal Investigator agree that, if either publishes the results of a Study or a Multi-Center Study, SPONSOR is hereby granted an irrevocable, royalty-free license to make and distribute copies of such publication under any copyright privileges that the Institution and the Principal Investigator may have, if any. SPONSOR also shall have the right to publish independently the results of each Study and each Multi-Center Study.
AutoNDA by SimpleDocs
License to SPONSOR. The Institution and the Principal Investigator agree that, if either publishes the results of a Study or a Multi-Center Study, SPONSOR is hereby granted an irrevocable, royalty-free license to make and distribute copies of such publication under any copyright privileges that the Institution and the Principal Investigator may have, if any. SPONSOR also shall have the right to publish independently the results of each Study and each Multi-Center Study. Clinical Trial Registries and Clinical Results Databases. SPONSOR is responsible for, and agrees to, register the Study and post the results information in accordance with the requirements of the Public Service Act, 42 U.S.C. 282(j)(1)(A), if applicable, as determined by SPONSOR. Institution agrees that it will not register the Study.
License to SPONSOR. GW hereby grants to Sponsor a non-exclusive, royalty-free, license to GW’s rights in GW Project IP for Sponsor’s non-commercial internal research use only, without the right to sublicense or redistribute.
License to SPONSOR. The Institution and the Principal Investigator agree that, if either publishes the results of the Multi-Center Study or the Study, SPONSOR is hereby granted an irrevocable, royalty-free license to make and distribute copies of such publication under any copyright privileges that the Institution and the Principal Investigator may have. SPONSOR also shall have the right to publish independently the results of the Multi-Center Study and the Study. The Institution and the Principal Investigator shall, in any agreement with a journal or other publisher to publish the results of the Multi-Center Study or the Study, use reasonable efforts to reserve expressly all copyright rights necessary to grant SPONSOR the license and rights contained herein.
License to SPONSOR. UEC hereby grants the Sponsor a non-exclusive, non-transferable, royalty-free license to use the Intellectual Property Rights for internal research purposes. The sponsor shall further be entitled to elect one of the license options set forth in Sections 7.1.1 and 7.1.2 by notice in writing to UEC within six (6) months after disclosure to the Sponsor of the Invention in accordance with Section 6.2.
License to SPONSOR. The Institution and the Principal Investigator agree that, if either publishes the results of a Trial or a Multi-Center Trial, SPONSOR is hereby granted an irrevocable, royalty-free license to make and distribute copies of such publication under any copyright privileges that the Institution and the Principal Investigator may have, if any. SPONSOR also shall have the right to publish independently the results of each Trial and each Multi-Center Trial. Clinical Trial Registries and Clinical Results Databases. SPONSOR is responsible for, and agrees to, register the Trial and post the results information in accordance with the requirements of the International Committee of Medical Journal Editors (ICMJE) the Public Service Act, 42 U.S.C. 282(j)(1)(A), if applicable, as determined by SPONSOR. Such registration shall be completed prior to enrollment of any Subject at Institution. Institution agrees that it will not register any Trial that has been registered by the SPONSOR.
License to SPONSOR. The Institution and the Principal Investigator agree that, if either publishes the results of a Study or a Multi-Center Study, SPONSOR is hereby granted an irrevocable, royalty-free license to make and distribute copies of such publication under any copyright privileges that the Institution and the Principal Investigator may have, if any. SPONSOR also shall have the right to publish independently the results of each Study and each Multi-Center Study. Clinical Trial Registries and Clinical Results Databases. SPONSOR is responsible for, and agrees to, register the Study and post the results information in accordance with the requirements of the International Committee of Medical Journal Editors (ICMJE) the Public Service Act, 42 U.S.C. 282(j)(1)(A), if applicable, as determined by SPONSOR. Such registration shall be completed prior to enrollment of any Subject at Institution. Institution agrees that it will not register any Study that has been registered by the SPONSOR.
AutoNDA by SimpleDocs

Related to License to SPONSOR

  • Right to Sublicense So long as COMPANY remains the exclusive licensee of the PATENT RIGHTS in the FIELD in the TERRITORY, COMPANY shall have the sole right to sublicense any alleged infringer in the FIELD in the TERRITORY for future use of the PATENT RIGHTS in accordance with the terms and conditions of this Agreement relating to sublicenses. Any upfront fees as part of such sublicense shall be shared equally between COMPANY and M.I.T.; other revenues to COMPANY pursuant to such sublicense shall be treated as set forth in Article 4.

  • Grant of License to Use Intellectual Property For the purpose of enabling the Notes Collateral Agent to exercise rights and remedies under this Agreement at such time as the Notes Collateral Agent shall be lawfully entitled to exercise such rights and remedies, each Grantor shall, upon request by the Notes Collateral Agent at any time after and during the continuance of an Event of Default, grant to the Notes Collateral Agent an irrevocable (until the termination of the Indenture) nonexclusive license (exercisable without payment of royalty or other compensation to the Grantors) to use, license or sublicense any of the Collateral now owned or hereafter acquired by such Grantor, and wherever the same may be located, and including in such license reasonable access to all media in which any of the licensed items may be recorded or stored and to all computer software and programs used for the compilation or printout thereof; provided, however, that nothing in this Section 3.03 shall require Grantors to grant any license that is prohibited by any rule of law, statute or regulation or is prohibited by, or constitutes a breach or default under or results in the termination of any contract, license, agreement, instrument or other document evidencing, giving rise to or theretofore granted, to the extent permitted by the Indenture, with respect to such property; provided, further, that such licenses to be granted hereunder with respect to Trademarks shall be subject to the maintenance of quality standards with respect to the goods and services on which such Trademarks are used sufficient to preserve the validity of such Trademarks. The use of such license by the Notes Collateral Agent may be exercised, at the option of the Notes Collateral Agent, during the continuation of an Event of Default; provided that any license, sublicense or other transaction entered into by the Notes Collateral Agent in accordance herewith shall be binding upon the Grantors notwithstanding any subsequent cure of an Event of Default.

  • The License 3.1.1 Subject to and in accordance with the terms and conditions set forth in this Agreement, and in particular subject to the due fulfillment of all the obligations assumed towards Maha-Metro by the Licensee, Maha-Metro hereby grants and authorizes the Licensee to the following (the “Specified Purpose”) :

  • Authorization of Agreement, Etc The Borrower has the right and power, and has taken all necessary action to authorize it, to borrow and obtain other extensions of credit hereunder. The Borrower and each other Loan Party has the right and power, and has taken all necessary action to authorize it, to execute, deliver and perform each of the Loan Documents to which it is a party in accordance with their respective terms and to consummate the transactions contemplated hereby and thereby. The Loan Documents to which the Borrower or any other Loan Party is a party have been duly executed and delivered by the duly authorized officers of such Person and each is a legal, valid and binding obligation of such Person enforceable against such Person in accordance with its respective terms except as the same may be limited by bankruptcy, insolvency, and other similar laws affecting the rights of creditors generally and the availability of equitable remedies for the enforcement of certain obligations (other than the payment of principal) contained herein or therein may be limited by equitable principles generally.

  • Sublicense (a) The license granted in Paragraph 2.1 includes the right of LICENSEE to grant Sublicenses to third parties during the Term but only for as long as the license to Patent Rights is exclusive.

  • Sublicense Agreements Sublicenses shall only be granted pursuant to written agreements, which shall be in compliance and not inconsistent with and shall be subject and subordinate to the terms and conditions of this Agreement (each, a "Sublicense Agreement"). Each such sublicense agreement shall contain, among other things, provisions to the following effect:

  • Effect of Termination on Sublicenses Any sublicenses granted by Company under this Agreement shall provide for termination or assignment to Hospital of Company’s interest therein, at the option of Hospital, upon termination of this Agreement or upon termination of any license hereunder under which such sublicense has been granted.

  • AUTHORIZATION TO SUPPLEMENT If any Grantor shall obtain rights to any new trademarks, the provisions of this Trademark Security Agreement shall automatically apply thereto. Grantors shall give prompt notice in writing to Agent with respect to any such new trademarks or renewal or extension of any trademark registration. Without limiting Grantors’ obligations under this Section, Grantors hereby authorize Agent unilaterally to modify this Trademark Security Agreement by amending Schedule I to include any such new trademark rights of each Grantor. Notwithstanding the foregoing, no failure to so modify this Trademark Security Agreement or amend Schedule I shall in any way affect, invalidate or detract from Agent’s continuing security interest in all Collateral, whether or not listed on Schedule I.

Time is Money Join Law Insider Premium to draft better contracts faster.